Posts

Holger Hanselka takes office as president of Fraunhofer...

“This farewell is far from being easy for me. After ten years of intense joint w...

Zhong named Institute of Food Technologists fellow

Qixin Zhong, professor in the University of Tennessee Department of Food Science...

University of Tennessee extension wins “Employer of the...

Ask just about any person in the University of Tennessee Extension family what t...

Arrays of quantum rods could enhance TVs or virtual rea...

Cambridge, MA – Flat screen TVs that incorporate quantum dots are now commercial...

Interdisciplinary team studies decomposition effects on...

Forensic researchers at the University of Tennessee Knoxville’s famous Anthropol...

Artificial intelligence designs advanced materials

In a world where annual economic losses from corrosion surpass 2.5 trillion US D...

Call for papers: Special theme issue: Artificial intell...

Asian/Pacific Island Nursing Journal (APINJ) Editor-in-Chief: Hyochol (Brian) Ah...

ORNL buildings researchers earn top ASHRAE honors

Kashif Nawaz and Mahabir Bhandari, building technologies researchers at the Depa...

For labrum tears, regrowth rather than repair

Tears to the glenoid labrum—cartilage tissue that lines the shoulder where the a...

Unlocking The Golden Benefits: Turmeric Supplements For...

In the realm of natural remedies and holistic health, few substances have garner...

CBD, CBN, and CBG — What’s The Difference?

The CBD market is booming, and our understanding of the functional hemp plant is...

Hims & Hers expects to establish a weight reduction com...

Hims & Hers, a company specializing in online health and wellness products, anno...

Merck and Ginkgo Forge $490 Million Partnership to Enha...

Merck has solidified a substantial collaboration valued at $490 million with Gin...

Phase 3 Approval of Novartis’ BTK Inhibitor Raises Conc...

Novartis is effectively navigating the competition to retain its foothold in the...

CD70 CAR-T by UTC Therapeutics for Mantle Cell Lymphoma...

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...

CD70 CAR-T by UTC Therapeutics for Burkitt Lymphoma: Li...

CD70 CAR-T is under clinical development by UTC Therapeutics and is currently in...